About Phil Skolnick
Phil Skolnick is a director at Gilgamesh Pharma.
Experience
This experience comes from Phil Skolnick's profile and from SEC filings. For roles taken from filings, the years are when the filings name Phil Skolnick in the role, so the role may have started earlier or lasted longer.
TT
æther THERAPEUTICS Current
Board Member
2026 – Present
GP
Gilgamesh Pharmaceuticals Current
Board Member
2021 – Present
TN
The National Institute on Drug Abuse (NIDA) Current
Scientist Emeritus
2017 – Present
Gilgamesh Pharma Inc.
Director
2026 · New York, NY
Develops medicines for people with psychiatric and neurological disorders.
IN
Indivior
Fellow
2023 – 2025
OP
Opiant Pharmaceuticals
Chief Scientific Officer
2017 – 2023
NH
National Institutes of Health
Division Director
1986 – 2017
DP
DOV Pharmaceutical
Chief Scientific Officer and President
2001 – 2009
NC
New York Univeristy Langone Medical Center
Research Professor of Psychiatry
2001 – 2009
EL
Eli Lilly
Lilly Fellow in Neuroscience
1997 – 2001
Key Colleagues at Startups
The people Phil Skolnick works with at each company, as listed on that company's latest Form D.
Gilgamesh Pharma Inc. · Form D, Mar 31, 2026
AK
Amy Kruse
Director
Jonathan Sporn
Founder, CEO and director
ZH
Zia Huque
Director
RB
Robert Berman
Director
Andrew Kruegel
Co-Founder, CSO and director